Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces that a recorded copy of the Friday, October 8, 2010 shareholders teleconference call is now available on the Company's website.

In that call, the Company's CEO, Kim Thompson reviewed: the recent development of recombinant spider silk technology; the Company's intellectual property and commercialization rights to this technology; the research and development pipeline; as well as revealing his vision for the future and growth of this biotechnology company.

Interested parties are invited to listen to the teleconference call with Kim Thompson, the Company's CEO and founder. The conference call is available on the Company's website homepage at http://www.KraigLabs.com.

Additionally, interested parties are encouraged by the Company to use the following link, http://www.youtube.com/watch?v=GnUupDb2Mvo, to view a video of the public press conference announcement concerning the recent scientific breakthrough.

Additional information is available on Kraig Biocraft Laboratories (KBLB) web site: http://www.KraigLabs.com.

Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

Contact: Ben Hansel (720) 288-8495 Email Contact

Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Kraig Biocraft Laborator... (QB) Charts.
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Kraig Biocraft Laborator... (QB) Charts.